or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level Zantac cases. The lawsuits claimed ...

GSK has reached ... 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has agreed to pay $2.2 billion to settle ...

Pfizer has agreed to settle more than 10,000 lawsuits which alleged that ... in the summer of 2022 after concerns about ...

To apply for a cash advance lawsuit loan from your anticipated GSK Zantac lawsuit settlement, please visit the company's website HERE or call 877.571.0405. Settlement monies are not expected ...

GSK last month agreed to settle about 80,000 Zantac lawsuits, representing most of the litigation against it, for $2.2 billion. Pfizer has also agreed to settle most of the outstanding cases ...

GSK’s shares ... slightly lower after it agreed a $2.2 billion settlement over lawsuits in the US, which alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer.

However, due to the size of the class and final amounts still not approved, we do not expect swift settlement payments." To apply for a cash advance lawsuit loan from your anticipated GSK Zantac ...